Company Filings — 27 April 2026

717 regulatory filings were published by NSE- and BSE-listed companies on 27 April 2026 — showing page 8 of 8.

  1. Addresses Stock Price Volatility Inquiry

    Elecon Engineering Company Limited · ELECON · NSE ·

    Responding to an inquiry from the National Stock Exchange (NSE) regarding significant movement in its stock price. Stated that there is no undisclosed information or pending announcement that could explain the recent price and volume behavior. The company affirms it is not connec…

  2. L&T Strengthens Realty Arm with Gurugram Acquisition & Consolidation Plan

    Larsen & Toubro Limited · LT · NSE ·

    L&T's subsidiary, L&T Realty, has acquired 100% of International Green Scapes Ltd, marking its first entry into the NCR (National Capital Region) real estate market. The acquisition includes 20 acres of land in Gurugram, adding a development potential of approximately 3.6 million…

  3. Completes 1:1 Bonus Share Allotment

    Anlon Healthcare Limited · 544497 · NSE ·

    The company has successfully allotted Bonus Equity Shares in a 1:1 ratio (one new share for every one existing share). The allotment was finalized on April 27, 2026, for shareholders on record as of April 24, 2026. As a result, the company's paid-up share capital has doubled to *…

  4. Achieves Major Milestone with New Armoured Vehicle Platform

    Bharat Forge Limited · BHARATFORG · NSE ·

    Announced the flag-off of its "Vikram VT 21" project, unveiling two new advanced armoured platforms developed in partnership with DRDO and Tata Advanced Systems. Crucially, the platform has cleared the Ministry of Defence's Technical Evaluation Committee (TEC), a significant step…

  5. Shareholders Approve Demerger of Commerce Business, Eyeing Separate Listing

    Veranda Learning Solutions Limited · VERANDA · NSE ·

    Equity shareholders have approved the demerger of the company's "Commerce Vertical" into a separate entity named J.K.Shah Commerce Education Limited. This move paves the way for a potential separate stock exchange listing of the new commerce entity, a key step aimed at unlocking…

  6. TARIL Reports Record Revenue & Enters HVDC Market, But Faces Execution Hurdles

    Transformers And Rectifiers (India) Limited · TARIL · NSE ·

    **Strong FY26 Performance:** Consolidated revenue grew 24.3% to ₹2,509 Crores, with the company achieving its highest-ever production of 33,763 MVA. **Robust Order Book:** The unexecuted order book stands at over ₹5,000 Crores, providing strong revenue visibility for the next 18…

  7. Major Leadership Change: Appoints Former Cipla CEO as New Executive Chairman & Group CEO

    Cohance Lifesciences Limited · COHANCE · NSE ·

    <b>New Leadership:</b> Mr. Umang Vohra, former CEO & MD of Cipla, has been appointed as the new Executive Chairman and Group CEO, effective May 2026. <b>Executive Departure:</b> Mr. Vivek Sharma is stepping down as Executive Chairman for personal reasons. <b>Smooth Transition:</b…

  8. Secures ₹150 Crore Export Order

    Transformers And Rectifiers (India) Limited · TARIL · NSE ·

    Secured a new export order from an international entity, PDC AK LPIV, LLC. The total value of the order is approximately **₹150 Crore** (USD 16.26 Million). The contract is for the manufacturing of 5 transformers and related work. The order is scheduled for delivery by mid-2027,…

  9. New Chairman & CEO Appointed; Board Approves Major ESOP Plan

    Cohance Lifesciences Limited · COHANCE · NSE ·

    • <b>Leadership Change:</b> Executive Chairman Mr. Vivek Sharma has resigned, effective April 30, 2026. He will continue as a Special Advisor for 9 months to ensure a smooth transition. • <b>New Appointments:</b> Mr. Umang Vohra has been appointed as the new Chairman (effective M…

  10. CFO Transition Announced

    Tata Elxsi Limited · TATAELXSI · NSE ·

    Mr. Gaurav Bajaj will step down as Chief Financial Officer (CFO), effective May 29, 2026. Mr. Nalin Rana has been appointed as the new CFO, effective May 30, 2026. Mr. Rana is a senior leader from the Tata Sons Group CFO and Strategy Office, with 17 years of experience in strateg…

  11. Tata Elxsi Appoints New Chief Financial Officer

    Tata Elxsi Limited · TATAELXSI · NSE ·

    Mr. Gaurav Bajaj has resigned as Chief Financial Officer (CFO), effective May 29, 2026, to pursue other career opportunities. The Board has appointed **Mr. Nalin Rana** as the new CFO, effective May 30, 2026. Mr. Rana is a senior leader from the Tata Sons Group CFO and Strategy O…

  12. Shareholders Approve ₹40 Crore Buyback at ₹250/Share

    Jagsonpal Pharmaceuticals Limited · JAGSNPHARM · NSE ·

    Shareholders have approved the company's proposal to buy back its equity shares. The buyback will be for an aggregate amount of up to ₹ 40 Crores at a price of ₹ 250 per share. The stated rationale is to enhance shareholder value, optimize capital structure, and improve Earnings…

  13. Launches India's First All-Black Solar Module

    Premier Energies Limited · PREMIERENE · NSE ·

    • Announced the launch of the "NeoBlack Series," India's first all-black G12R DCR solar module, targeting the residential and premium commercial rooftop market. • The new module features high power output (up to 630 Wp), next-gen TOPCon cell technology, and a 30-year power output…

  14. Share Buyback Approved by Shareholders

    Jagsonpal Pharmaceuticals Limited · JAGSNPHARM · NSE ·

    Shareholders have approved a proposal for the company to buy back up to **16,00,000 equity shares**. The buyback price is fixed at **₹250 per share**, with a total outlay not exceeding **₹40 crores**. The Special Resolution was passed with an overwhelming majority of **99.99%** o…

  15. To Acquire Organon & Co. in a Transformative $11.75 Bn Deal

    Sun Pharmaceutical Industries Limited · SUNPHARMA · NSE ·

    Announced the proposed acquisition of Organon & Co. for an Enterprise Value of **$11.75 Bn** ($14.0 per share). The deal will create a combined entity with pro-forma revenue of **~$12.4 Bn** and EBITDA of **~$3.7 Bn**, effectively doubling the company's scale. Strategically, the…

  16. Announces Acquisition of Organon & Co. and Schedules Investor Call

    Sun Pharmaceutical Industries Limited · SUNPHARMA · NSE ·

    The company has announced the acquisition of Organon & Co., marking a significant strategic initiative. An investor call with senior management is scheduled for April 27, 2026, at 8:00 AM IST to discuss the acquisition. The call will provide updates on the valuation, strategic fi…

  17. To Acquire Organon & Co. for ~$4 Billion in All-Cash Deal

    Sun Pharmaceutical Industries Limited · SUNPHARMA · NSE ·

    • Sun Pharma will acquire 100% of Organon & Co. (NYSE: OGN) in an all-cash transaction for an equity value of approximately $3.99 billion. • The deal values Organon at $14.00 per share, with a total enterprise value of approximately $11.75 billion. • This strategic acquisition wi…